Home
About Us
Journal Overview Aims And Scope Editorial Board Permissions Copyright
Current Archive
Submission Guidelines
Editorial Policy
Peer Review Reviewer Responsibilities Scientific Integrity Retraction Policy Disclaimer
News Contact
×
Home

Journal Overview Aims And Scope Editorial Board Permissions Copyright
Current Archive Submission Guidelines

Peer Review Reviewer Responsibilities Scientific Integrity Retraction Policy Disclaimer
News Contact
Research paper
Published: 01.12.2020.
<< Prev | Next >>
PDF
https://doi.org/10.5937/afmnai38-31596

Ertapenem neurotoxicity in patients with kidney damage: A case report

By
Alper Alp ,
Alper Alp
View authors publications

Search this author on:

PubMed | Google Scholar
Yalkin Dalda
Yalkin Dalda
View authors publications

Search this author on:

PubMed | Google Scholar

Abstract

Ertapenem, a member of the carbapenem group of antibiotics, is a broad-spectrum antibiotic that is effective against multidrug-resistant gram-positive and gram-negative infections. In patients with acute or chronic kidney damage, one of the most serious side effects of ertapenem is neurotoxicity. Various clinical conditions such as seizures, hallucinations, delirium, confusion, and nystagmus may occur. Previous history of cerebral pathologies is a known risk factor for ertapenem-associated neurotoxicity. Immediate discontinuation of treatment is required. Although the symptoms usually resolve rapidly, cases with longer duration of symptoms have also been reported. Close monitoring of neurological status in such patients is essential.

References

1.
Deshayes S, Coquerel A, Verdon R. Neurological Adverse Effects Attributable to β-Lactam Antibiotics: A Literature Review. Drug Safety. 2017;40(12):1171–98.

Citation

Copyright

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Article metrics

Google scholar: See link
Issue image
Vol 38, Issue 3, 2021
Possible health benefits of polyphenols in neurological disorders associated with COVID-19 The burden of tuberculosis as a permanent medical and legal challenge for mankind through centuries Chronic chloroquine and ethanol administration causes detrimental renal morphological changes in rats fed low protein Treatment satisfaction in patients with diabetes mellitus type 1 treated with intensified insulin therapy with insulin analogues Effectiveness of Tocilizumab after switching from intravenous to subcutaneous formulation in patients with rheumatoid arthritis: A single-centre experience See full issue
Widget Side

The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.